Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $3.24 Million - $4.22 Million
39,367 Added 1100.56%
42,944 $3.55 Million
Q2 2022

Aug 11, 2022

SELL
$86.5 - $128.27 $202,496 - $300,280
-2,341 Reduced 39.56%
3,577 $340,000
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $95,026 - $119,612
-932 Reduced 13.61%
5,918 $697,000
Q4 2021

Feb 09, 2022

SELL
$106.37 - $130.68 $1.58 Million - $1.94 Million
-14,861 Reduced 68.45%
6,850 $887,000
Q3 2021

Nov 10, 2021

BUY
$102.91 - $122.75 $1.28 Million - $1.52 Million
12,415 Added 133.55%
21,711 $2.46 Million
Q2 2021

Aug 12, 2021

SELL
$83.84 - $104.76 $3.53 Million - $4.42 Million
-42,148 Reduced 81.93%
9,296 $963,000
Q1 2021

May 13, 2021

BUY
$78.68 - $90.67 $2.68 Million - $3.09 Million
34,031 Added 195.43%
51,444 $4.3 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $216,145 - $275,058
3,015 Added 20.94%
17,413 $1.59 Million
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $1.69 Million - $2.2 Million
-25,195 Reduced 63.63%
14,398 $1.15 Million
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $1.77 Million - $2.36 Million
30,707 Added 345.57%
39,593 $2.74 Million
Q1 2020

May 13, 2020

BUY
$52.41 - $81.0 $9,381 - $14,499
179 Added 2.06%
8,886 $1.68 Million
Q4 2019

Feb 12, 2020

BUY
$71.7 - $82.09 $323,151 - $369,979
4,507 Added 107.31%
8,707 $2.03 Million
Q3 2019

Nov 12, 2019

SELL
$61.55 - $75.43 $466,918 - $572,211
-7,586 Reduced 64.36%
4,200 $924,000
Q2 2019

Aug 12, 2019

BUY
$55.74 - $64.41 $545,415 - $630,251
9,785 Added 489.01%
11,786 $2.18 Million
Q1 2019

May 10, 2019

SELL
$47.89 - $64.05 $100,521 - $134,440
-2,099 Reduced 51.2%
2,001 $383,000
Q4 2018

Feb 11, 2019

BUY
$46.41 - $56.94 $190,281 - $233,454
4,100 New
4,100 $628,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.